2022 Q3 Form 10-Q Financial Statement
#000121390022048121 Filed on August 15, 2022
Income Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $179.7K | $232.7K | |
YoY Change | |||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $179.7K | $232.7K | $5.010K |
YoY Change | |||
Operating Profit | -$179.7K | -$232.7K | -$5.010K |
YoY Change | 1123187.5% | ||
Interest Expense | $312.2K | $146.4K | |
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $678.4K | -$122.5K | |
YoY Change | |||
Pretax Income | $810.9K | -$208.8K | -$5.010K |
YoY Change | |||
Income Tax | $79.75K | ||
% Of Pretax Income | 9.84% | ||
Net Earnings | $731.1K | -$208.8K | -$5.010K |
YoY Change | -4569606.25% | ||
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $49.05K | -$14.45K | -$386.10 |
COMMON SHARES | |||
Basic Shares Outstanding | 14.91M shares | ||
Diluted Shares Outstanding | 2.500M shares |
Balance Sheet
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $414.1K | $447.4K | $6.670K |
YoY Change | |||
Cash & Equivalents | $414.1K | $447.4K | $6.670K |
Short-Term Investments | |||
Other Short-Term Assets | $141.0K | $218.2K | $250.3K |
YoY Change | |||
Inventory | |||
Prepaid Expenses | $141.0K | $218.2K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $555.1K | $665.6K | $256.9K |
YoY Change | |||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $116.6M | $116.3M | |
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $116.6M | $116.3M | $0.00 |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $555.1K | $665.6K | $256.9K |
Total Long-Term Assets | $116.6M | $116.3M | $0.00 |
Total Assets | $117.2M | $117.0M | $256.9K |
YoY Change | |||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | $60.00K | $30.00K | $40.50K |
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $200.0K |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $218.4K | $69.30K | $240.5K |
YoY Change | |||
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $4.344M | $5.023M | |
YoY Change | |||
Total Long-Term Liabilities | $4.344M | $5.023M | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $218.4K | $69.30K | $240.5K |
Total Long-Term Liabilities | $4.344M | $5.023M | $0.00 |
Total Liabilities | $4.563M | $5.092M | $240.5K |
YoY Change | |||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$4.008M | -$4.280M | |
YoY Change | |||
Common Stock | $340.00 | $340.00 | $287.00 |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$4.008M | -$4.280M | $16.43K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $117.2M | $117.0M | $256.9K |
YoY Change |
Cashflow Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $731.1K | -$208.8K | -$5.010K |
YoY Change | -4569606.25% | ||
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$33.24K | -$392.9K | $6.290K |
YoY Change | |||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | -$116.2M | |
YoY Change | |||
Cash From Investing Activities | $0.00 | -$116.2M | |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 117.0M | -4.570K |
YoY Change | |||
NET CHANGE | |||
Cash From Operating Activities | -33.24K | -392.9K | 6.290K |
Cash From Investing Activities | 0.000 | -116.2M | |
Cash From Financing Activities | 0.000 | 117.0M | -4.570K |
Net Change In Cash | -33.24K | 440.7K | 1.720K |
YoY Change | |||
FREE CASH FLOW | |||
Cash From Operating Activities | -$33.24K | -$392.9K | $6.290K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-41340 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Redwoods Acquisition Corp. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
86-2727441 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1115 Broadway | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
12th Floor | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
New York | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10010 | ||
dei |
City Area Code
CityAreaCode
|
(646) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
916-5315 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock | ||
dei |
Trading Symbol
TradingSymbol
|
RWOD | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
CY2022Q2 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
116296397 | usd |
CY2022Q2 | us-gaap |
Assets
Assets
|
116961952 | usd |
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2022Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
14905000 | shares |
CY2022Q2 | us-gaap |
Cash
Cash
|
447382 | usd |
CY2021Q4 | us-gaap |
Cash
Cash
|
4952 | usd |
CY2022Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
218173 | usd |
CY2022Q2 | us-gaap |
Assets Current
AssetsCurrent
|
665555 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4952 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
4952 | usd |
CY2022Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
30000 | usd |
CY2022Q2 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
39300 | usd |
CY2021Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
8511 | usd |
CY2022Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
69300 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8511 | usd |
CY2022Q2 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
710200 | usd |
CY2022Q2 | rwodu |
Deferred Underwriting Fee Payables
DeferredUnderwritingFeePayables
|
4312500 | usd |
CY2022Q2 | us-gaap |
Liabilities
Liabilities
|
5092000 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
8511 | usd |
CY2022Q2 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
11500000 | |
CY2021Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
11500000 | |
CY2022Q2 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.1 | |
CY2021Q4 | us-gaap |
Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
|
10.1 | |
CY2022Q2 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
116150000 | usd |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3405000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3405000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
0 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
0 | shares |
CY2022Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
340 | usd |
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-4280388 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3559 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4280048 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3559 | usd |
CY2022Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
116961952 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4952 | usd |
CY2022Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
193440 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
198450 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3511 | usd | |
CY2022Q2 | us-gaap |
Franchisor Costs
FranchisorCosts
|
39300 | usd |
us-gaap |
Franchisor Costs
FranchisorCosts
|
39300 | usd | |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-232740 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-237750 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3511 | usd | |
CY2022Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
146397 | usd |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
146397 | usd | |
CY2022Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
122483 | usd |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
122483 | usd | |
CY2022Q2 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-208826 | usd |
us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-213836 | usd | |
us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-3511 | usd | |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-208826 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-213836 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3511 | usd | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3559 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5010 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
16431 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
115000000 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
|
5300000 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
100 | usd |
CY2022Q2 | rwodu |
Stock Issued During Period Value Underwriter Commissions
StockIssuedDuringPeriodValueUnderwriterCommissions
|
-7187500 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
-462536 | usd |
CY2022Q2 | rwodu |
Stock Issued During Period Value Warrant Liabilities
StockIssuedDuringPeriodValueWarrantLiabilities
|
-587717 | usd |
CY2022Q2 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
96338934 | usd |
CY2022Q2 | us-gaap |
Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
|
6901405 | usd |
CY2022Q2 | us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
26712471 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-208826 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4280048 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3511 | usd | |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3511 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-213836 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3511 | usd | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
146397 | usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
122483 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
218173 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
30000 | usd | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
39300 | usd | |
us-gaap |
Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
|
3511 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-386623 | usd | |
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
116150000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-116150000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
25000 | usd | |
us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
115000000 | usd | |
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
5300000 | usd | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
100 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
200000 | usd | |
us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
-200000 | usd | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
8511 | usd | |
rwodu |
Payment Of Underwriters Commissions
PaymentOfUnderwritersCommissions
|
2875000 | usd | |
rwodu |
Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
|
462536 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
116979053 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
442430 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4952 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
447382 | usd |
rwodu |
Initial Classification Of Common Stock Subject To Redemption
InitialClassificationOfCommonStockSubjectToRedemption
|
96338934 | usd | |
us-gaap |
Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
|
587717 | usd | |
us-gaap |
Other Underwriting Expense
OtherUnderwritingExpense
|
4312500 | usd | |
rwodu |
Allocation Of Offering Costs To Common Stock Subject To Redemption
AllocationOfOfferingCostsToCommonStockSubjectToRedemption
|
6901405 | usd | |
rwodu |
Accretion Of Common Stock To Redemption Value
AccretionOfCommonStockToRedemptionValue
|
26712471 | usd | |
CY2022Q2 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
10 | |
CY2022Q2 | rwodu |
Gross Proceeds
GrossProceeds
|
100000000 | usd |
CY2022Q2 | rwodu |
Total Gross Proceeds
TotalGrossProceeds
|
4775000 | usd |
rwodu |
Additional Public Units
AdditionalPublicUnits
|
1500000 | shares | |
CY2022Q2 | rwodu |
Purchased Public Units
PurchasedPublicUnits
|
1500000 | shares |
CY2022Q2 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
10 | |
CY2022Q2 | rwodu |
Gross Proceeds
GrossProceeds
|
15000000 | usd |
CY2022Q2 | rwodu |
Total Gross Proceeds
TotalGrossProceeds
|
525000 | usd |
CY2022Q2 | us-gaap |
Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
|
8365339 | usd |
rwodu |
Underwriting Fees
UnderwritingFees
|
2875000 | usd | |
rwodu |
Deferred Underwriting Fees
DeferredUnderwritingFees
|
4312500 | usd | |
rwodu |
Other Offering Costs
OtherOfferingCosts
|
1177839 | usd | |
CY2022Q2 | rwodu |
Total Amount
TotalAmount
|
116150000 | usd |
CY2022Q2 | us-gaap |
Debt Instrument Term
DebtInstrumentTerm
|
P185D | |
rwodu |
Description Of Business Combination Percentage
DescriptionOfBusinessCombinationPercentage
|
the Company’s initial Business Combination must occur with one or more target businesses having an aggregate fair market value equal to at least 80% of the value of the funds in the Trust account (excluding any deferred underwriting discounts and commissions and taxes payable on the income earned on the Trust Account), which the Company refers to as the 80% test, at the time of the execution of a definitive agreement for its initial Business Combination, although the Company may structure a Business Combination with one or more target businesses whose fair market value significantly exceeds 80% of the trust account balance. If the Company is no longer listed on Nasdaq, it will not be required to satisfy the 80% test. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. | ||
CY2022Q2 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
10.1 | |
us-gaap |
Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
|
1 | pure | |
CY2022Q2 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
10.1 | |
CY2022Q2 | us-gaap |
Cash Available For Distributions
CashAvailableForDistributions
|
447382 | usd |
CY2022Q2 | rwodu |
Working Capital Deficit
WorkingCapitalDeficit
|
596255 | usd |
us-gaap |
Payments To Suppliers
PaymentsToSuppliers
|
25000 | usd | |
rwodu |
Promissory Note Receivable From Related Parties
PromissoryNoteReceivableFromRelatedParties
|
200000 | usd | |
us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
116 | usd | |
CY2022Q2 | rwodu |
Offering Costs Of Public Shares
OfferingCostsOfPublicShares
|
-6901405 | usd |
rwodu |
Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
|
26712471 | usd | |
rwodu |
Class A Common Stock Subject To Possible Redemption
ClassACommonStockSubjectToPossibleRedemption
|
116150000 | usd | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
usd | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these unaudited condensed financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 6pt"> </span></p> | ||
us-gaap |
Dividends Cash
DividendsCash
|
447382 | usd | |
CY2022Q2 | us-gaap |
Other Additional Capital
OtherAdditionalCapital
|
1500000 | usd |
CY2022Q2 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
8365339 | usd |
CY2022Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-208826 | usd |
us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-213836 | usd | |
CY2022Q2 | us-gaap |
Temporary Equity Other Changes
TemporaryEquityOtherChanges
|
-26712471 | usd |
us-gaap |
Temporary Equity Other Changes
TemporaryEquityOtherChanges
|
-26712471 | usd | |
CY2022Q2 | rwodu |
Net Loss Including Accretion Of Common Stock To Redemption Value
NetLossIncludingAccretionOfCommonStockToRedemptionValue
|
26921297 | usd |
rwodu |
Net Loss Including Accretion Of Common Stock To Redemption Value
NetLossIncludingAccretionOfCommonStockToRedemptionValue
|
26926307 | usd | |
CY2022Q2 | us-gaap |
Long Term Debt Term
LongTermDebtTerm
|
P5Y | |
us-gaap |
Partners Capital Account Units Sold In Public Offering
PartnersCapitalAccountUnitsSoldInPublicOffering
|
11500000 | shares | |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentration of Credit Risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution and money market funds held in the Trust Account. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. As of June 30, 2022 and December 31, 2021, approximately $116 million and $Nil, respectively, was over the Federal Deposit Insurance Corporation (FDIC) limit.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> | ||
us-gaap |
Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
|
116296397 | usd | |
CY2022Q2 | us-gaap |
Assets Held In Trust Current
AssetsHeldInTrustCurrent
|
116296397 | usd |
rwodu |
Gross Proceed
GrossProceed
|
115000000 | usd | |
CY2022Q2 | rwodu |
Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
|
-9917024 | usd |
CY2022Q2 | rwodu |
Proceeds Allocated To Public Rights
ProceedsAllocatedToPublicRights
|
-8744042 | usd |
rwodu |
Aggregate Private Units
AggregatePrivateUnits
|
477500 | shares | |
CY2022Q2 | rwodu |
Sale Of Stock Price Per Shares
SaleOfStockPricePerShares
|
10 | |
rwodu |
Aggregate Purchase Price
AggregatePurchasePrice
|
4775000 | usd | |
rwodu |
Additional Aggregates Private Units
AdditionalAggregatesPrivateUnits
|
52500 | shares | |
us-gaap |
Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
|
525000 | usd | |
rwodu |
Initial Stockholders Description
InitialStockholdersDescription
|
The Initial Stockholders have agreed, subject to certain limited exceptions, not to transfer, assign or sell any of their Insider Shares until, with respect to 50% of the Insider Shares, the earlier of six months after the consummation of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing after a Business Combination and, with respect to the remaining 50% of the Insider Shares, until the six months after the consummation of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. | ||
CY2022Q1 | rwodu |
Aggregate Amount
AggregateAmount
|
200000 | usd |
CY2022Q1 | rwodu |
Aggregate Amount
AggregateAmount
|
200000 | usd |
us-gaap |
Interest Costs Incurred
InterestCostsIncurred
|
30000 | usd | |
rwodu |
Accrued Expenses
AccruedExpenses
|
30000 | usd | |
CY2022Q2 | us-gaap |
Interest Costs Incurred
InterestCostsIncurred
|
30000 | usd |
CY2022Q2 | rwodu |
Prospectus To Purchase
ProspectusToPurchase
|
1500000 | shares |
us-gaap |
Underwriting Expense Ratio
UnderwritingExpenseRatio
|
0.025 | pure | |
rwodu |
Generating Gross Proceeds
GeneratingGrossProceeds
|
2875000 | usd | |
rwodu |
Deferred Fee
DeferredFee
|
0.0375 | pure | |
CY2022Q2 | us-gaap |
Purchase Options Land
PurchaseOptionsLand
|
100 | usd |
rwodu |
Unit Purchase Option
UnitPurchaseOption
|
345000 | shares | |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
11.5 | |
CY2022Q2 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
3967500 | shares |
us-gaap |
Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
|
P5Y | ||
us-gaap |
Dividends Share Based Compensation Cash
DividendsShareBasedCompensationCash
|
100 | usd | |
rwodu |
Market Price Percentage
MarketPricePercentage
|
1.15 | pure | |
rwodu |
Market Valuein Percentage
MarketValueinPercentage
|
1.65 | pure | |
CY2022Q2 | us-gaap |
Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
|
16.5 | |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
usd | |
rwodu |
Right Of First Refusal Description
RightOfFirstRefusalDescription
|
The Company has granted Chardan a right of first refusal, for a period of 18 months after the date of the consummation of a Business Combination, to act as a book-running manager or placement agent, with at least 30% of the economics, for any and all future public and private equity, equity linked and debt offerings of the Company or any of its successors or subsidiaries. | ||
CY2022Q2 | rwodu |
Price Per Warrant
PricePerWarrant
|
0.01 | |
us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
16.5 | ||
CY2022Q2 | rwodu |
Warrants Liability
WarrantsLiability
|
710200 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
usd | |
CY2022Q2 | rwodu |
Fair Value
FairValue
|
587717 | usd |
rwodu |
Change In Fair Value
ChangeInFairValue
|
122483 | usd | |
CY2022Q2 | us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
|
710200 | usd |
CY2022Q2 | rwodu |
Fair Value Of Private Warrants
FairValueOfPrivateWarrants
|
529495 | usd |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
11.5 | |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
11.5 | |
CY2022Q2 | rwodu |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Underlying Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsUnderlyingSharePrice
|
7.88 | |
CY2022Q2 | rwodu |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Underlying Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsUnderlyingSharePrice
|
8.08 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.3307 | pure | |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.2562 | pure |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | ||
CY2022Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0301 | pure | |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0242 | pure |
rwodu |
Initial Classification Of Common Stock Subject To Redemption
InitialClassificationOfCommonStockSubjectToRedemption
|
usd | ||
us-gaap |
Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
|
usd | ||
us-gaap |
Other Underwriting Expense
OtherUnderwritingExpense
|
usd | ||
rwodu |
Allocation Of Offering Costs To Common Stock Subject To Redemption
AllocationOfOfferingCostsToCommonStockSubjectToRedemption
|
usd | ||
CY2021Q4 | rwodu |
Deferred Underwriting Fee Payables
DeferredUnderwritingFeePayables
|
usd | |
CY2021Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
usd | |
us-gaap |
Franchisor Costs
FranchisorCosts
|
usd | ||
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
usd | ||
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | ||
CY2021Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | ||
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
usd | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
usd | ||
us-gaap |
Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
|
usd | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
usd | ||
us-gaap |
Payments To Acquire Investments
PaymentsToAcquireInvestments
|
usd | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | ||
us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
usd | ||
us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
usd | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
usd | ||
us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
usd | ||
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
usd | ||
rwodu |
Payment Of Underwriters Commissions
PaymentOfUnderwritersCommissions
|
usd | ||
rwodu |
Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
|
usd | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
usd | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
usd | ||
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
usd | |
rwodu |
Accretion Of Common Stock To Redemption Value
AccretionOfCommonStockToRedemptionValue
|
usd | ||
CY2022Q2 | us-gaap |
Long Term Debt Term
LongTermDebtTerm
|
P5Y | |
CY2021Q4 | rwodu |
Warrants Liability
WarrantsLiability
|
usd | |
CY2021Q4 | us-gaap |
Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
|
usd | |
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001907223 |